Navigation Links
Third Wave agrees to drop Chiron, Bayer patent lawsuits

Madison, Wis. Third Wave Technologies Inc. said it has reached an agreement with Chiron Corp., Bayer Corp., and Bayer HealthCare, LLC, to dismiss Third Wave's patent lawsuit.

Third Wave said that no licenses or payments were made and did not disclose other terms of the agreement.

This leaves Third Wave with only one remaining open patent l......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 02/23/06


Page: 1

Related biology technology :

1. Third Wave files countersuit vs. Digene in patent case
2. Third Wave reports net loss of $18.9M for 2006
3. Stratagene to pay Third Wave $10.75M in patent case
4. Third Wave responds to Digene patent lawsuit
5. Third Wave seeks approval of Cystic Fibrosis test
6. Third Wave Technologies to raise $14.9M through private debt
7. Third Wave reports $5.2M third quarter loss
8. Third Wave reports another loss, stronger sales
9. Napier joins board of Third Wave Technologies
10. Third Waves revenues rebound
11. Third Wave reports clinical growth, continued loss
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... , March 22, 2017  Personal Genome Diagnostics ... cancer testing contract with the U.S. Department of ... profiling assay with the company,s new CancerSELECT ™ ... clinically actionable pan-cancer profiling test that includes microsatellite ... potential patient response to checkpoint inhibitor immunotherapies. CancerSELECT ...
(Date:3/22/2017)... 2017   Invitae Corporation (NYSE: NVTA), ... today announced the availability of a new genetic ... Atrophy (SMA) , a neuromuscular disease that is ... infants as well as a significant cause of ... announced during the American College of Medical Genetics ...
(Date:3/20/2017)... ... March 20, 2017 , ... ... hormones to regulate homeostasis via their cognate nuclear receptors. By either mimicking ... neurological, proliferative, and immunological disorders. EDC exposure can occur directly, through the ...
(Date:3/20/2017)... San Diego, CA (PRWEB) , ... March 20, ... ... developing novel therapies for gastrointestinal (GI) disorders, today announced that it has entered ... Neuregulin-4 (NRG-4) for therapies in inflammatory bowel disease including Necrotizing Enterocolitis (rare orphan ...
Breaking Biology Technology:
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ein ... wird seine erstklassige biometrische Lösung zur Iris-Erkennung ... mit X16 LTE auf dem Mobile World ... am Qualcomm-Stand in Halle 3, Stand 3E10, ... die Sicherheitsplattform Qualcomm Haven™ – eine Kombination ...
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. ... the Avamere Family of Companies (Avamere Health Services, Infinity ... a six-month research study that will apply the power ... at senior living and health centers. By analyzing data ... to gain insights into physical and environmental conditions, and ...
(Date:2/13/2017)... WASHINGTON , Feb. 13, 2017 Former ... U.S. Senate Judiciary Committee, Janice Kephart of ... regarding President Donald Trump,s "Executive Order: Protecting ... States" (Jan. 27, 2017):  "As President Trump,s ... 9th Circuit has now essentially banned the travel ban, ...
Breaking Biology News(10 mins):